Last reviewed · How we verify

Vinbiocare Biotechnology Joint Stock Company — Portfolio Competitive Intelligence Brief

Vinbiocare Biotechnology Joint Stock Company pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Jiangsu Province Centers for Disease Control and Prevention · 1 shared drug class
  2. University Medical Center Groningen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Vinbiocare Biotechnology Joint Stock Company:

Cite this brief

Drug Landscape (2026). Vinbiocare Biotechnology Joint Stock Company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vinbiocare-biotechnology-joint-stock-company. Accessed 2026-05-17.

Related